Physicians
Write a Review

Lalit Aneja, MD

Dr. Aneja is an Oncologist, Hematologist and Internist for Florida Cancer Specialists and Research Institute in Charlotte and Sarasota Counties. After earning his undergraduate medical degree, Dr. Lalit Aneja completed his residency and fellowship in Hematology/Oncology at NYU Winthrop Hospital in Mineola, NY, which is a major teaching affiliate of NYU. There, Dr. Aneja served as Chief Fellow and as a Clinical Instructor in Internal Medicine for third and fourth year medical students, and he supervised interns. He has served as a sub-investigator for several clinical trials and, in 2015, was published in the prestigious Journal of Clinical Oncology. He is Board-certified in Medical Oncology/Hematology and Internal Medicine.

In his personal life, Dr. Aneja enjoys travel and spending time with his wife and daughter. He is fluent in three languages.

Treatments Provided
  • Hematology
  • Internal Medicine
  • Medical Oncology
Languages Spoken
  • English
  • Hindi
  • Punjabi

Medical School

  • Kasturba Medical College – Manipal, India

Residency

  •  NYU Langone Hospital Long Island

Fellowship

  • Oncology/Hematology  –  NYU Langone Hospital Long Island

Board Certified

  • Medical Oncology
  • Hematology
  • Internal Medicine

Honors & Achievements

  • Best Academic Performance in Final Year of Medical School
  • Poster of Distinction Award at Annual Research Day at Winthrop University Hospital 2011
  • Poster of Distinction Award at Annual Research Day at Winthrop University Hospital 2012
  • Fellow Representative (07/2014-Present)
  • Chief Fellow: Hematology-Oncology (07/2015-Present)

Professional Affiliations

  • American Society of Clinical Oncology (ASCO), Member in Training
  • American Society of Hematology (ASH), Associate Member
  • American College of Physicians

Interests

  • Travel, spending time with family
Dr. Lalit Aneja - Florida Cancer Specialists

Dr. Lalit Aneja, Medical Oncologist, explains how the field is evolving and how clinical research is a main contributing factor to the recent advancements in cancer care